Clinical trial · no report yet · Phase not applicable
PLATON
Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer
- NCT03784755 ↗
- Active, not recruiting
- Canadian Cancer Trials Group
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| YouTube | 2 | |
| X threads | 1 |
The trial
ClinicalTrials.gov- Official title
- A Randomized Phase III Trial of Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer [PLATON]
- Phase
- Phase not applicable
- Status
- Active, not recruiting
- Conditions
- Prostate Cancer Metastatic
- Interventions
- Ablative Radiation Therapy; Standard of care
- Arms
- Arm 1 (standard of care) · Active comparator
- Arm 2 (standard systemic therapy + ablative therapy)) · Experimental
- Enrollment
- 409
- Primary outcomes
- Failure-free Survival
- Sponsor
- Canadian Cancer Trials Group with Canadian Cancer Society (CCS)
- Start
- Nov 15, 2019
- Primary completion
- Dec 31, 2032 (estimated)
- Results posted
- No
- Registry record
- NCT03784755 · updated Mar 27, 2026